COMMONWEALTH EQUITY SERVICES, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$293
-6.1%
18,899
-3.5%
0.00%
-100.0%
Q1 2024$312
-8.2%
19,583
-3.2%
0.00%0.0%
Q4 2023$340
+69.2%
20,221
+17.7%
0.00%
Q3 2023$201
-37.8%
17,180
-28.4%
0.00%
-100.0%
Q2 2023$323
-5.6%
24,004
+16.3%
0.00%0.0%
Q1 2023$342
-9.0%
20,644
+2.0%
0.00%0.0%
Q4 2022$376
-99.8%
20,236
+27.1%
0.00%0.0%
Q3 2022$204,000
+114.7%
15,918
+16.3%
0.00%
Q2 2022$95,000
+6.7%
13,685
+26.7%
0.00%
Q1 2022$89,000
+2.3%
10,800
-16.0%
0.00%
Q4 2021$87,000
+35.9%
12,855
+5.2%
0.00%
Q3 2021$64,000
+1.6%
12,214
+10.5%
0.00%
Q2 2021$63,000
+26.0%
11,0560.0%0.00%
Q1 2021$50,000
+22.0%
11,056
-10.2%
0.00%
Q4 2020$41,000
+5.1%
12,315
-7.5%
0.00%
Q3 2020$39,000
-36.1%
13,3150.0%0.00%
Q2 2020$61,000
-1.6%
13,315
-18.4%
0.00%
Q1 2020$62,000
+1.6%
16,3150.0%0.00%
Q4 2019$61,000
-29.1%
16,3150.0%0.00%
Q3 2019$86,000
+30.3%
16,315
-5.8%
0.00%
Q2 2019$66,000
-54.8%
17,315
-39.9%
0.00%
-100.0%
Q1 2019$146,000
+175.5%
28,815
+3.6%
0.00%
Q4 2018$53,000
-41.8%
27,815
+14.4%
0.00%
Q3 2018$91,000
+18.2%
24,315
-2.0%
0.00%
Q2 2018$77,000
+30.5%
24,8150.0%0.00%
Q1 2018$59,000
-39.2%
24,8150.0%0.00%
-100.0%
Q4 2017$97,00024,8150.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 17,875,655$94,920,0009.39%
TANAKA CAPITAL MANAGEMENT INC 283,334$1,505,0004.86%
GABLES CAPITAL MANAGEMENT INC. 490,564$2,606,0001.84%
MANGROVE PARTNERS IM, LLC 2,508,838$13,322,0001.61%
Broadfin Capital, LLC 880,303$4,674,0000.86%
Atom Investors LP 1,012,355$5,376,0000.37%
Capital Impact Advisors, LLC 179,868$948,0000.36%
KNOTT DAVID M 151,415$804,0000.34%
EMERALD ADVISERS, LLC 1,175,958$6,244,0000.29%
CADENCE CAPITAL MANAGEMENT LLC 371,075$1,970,0000.28%
View complete list of CATALYST PHARMACEUTICALS INC shareholders